According to SurModics's latest financial reports the company's total assets are $0.18 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-09-30 | $0.18 B | 17.29% |
2022-09-30 | $0.15 B | -18.62% |
2021-09-30 | $0.19 B | 15.3% |
2020-09-30 | $0.16 B | 5.57% |
2019-09-30 | $0.15 B | -2.6% |
2018-09-30 | $0.16 B | 20.16% |
2017-09-30 | $0.13 B | 2.78% |
2016-09-30 | $0.13 B | 34.63% |
2015-09-30 | $98.71 M | -5.89% |
2014-09-30 | $0.10 B | 2.91% |
2013-09-30 | $0.10 B | -2.3% |
2012-09-30 | $0.10 B | -33.46% |
2011-09-30 | $0.15 B | -7.93% |
2010-09-30 | $0.17 B | -8.24% |
2009-09-30 | $0.18 B | -2.86% |
2008-09-30 | $0.19 B | 11.5% |
2007-09-30 | $0.17 B | 8.85% |
2006-09-30 | $0.15 B | 26.71% |
2005-09-30 | $0.12 B | 13.36% |
2004-09-30 | $0.10 B | 12.04% |
2003-09-30 | $97.8 M | 26.62% |
2002-09-30 | $77.24 M | 27.51% |
2001-09-30 | $60.58 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 92,863.83% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | 40,520.28% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | $98.72 B | 54,674.74% | ๐บ๐ธ USA |
Agilent Technologies A | $10.94 B | 5,974.12% | ๐บ๐ธ USA |
PerkinElmer
PKI | $14.63 B | 8,021.50% | ๐บ๐ธ USA |
Alkermes ALKS | $2.13 B | 1,085.21% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | $0.39 B | 120.83% | ๐บ๐ธ USA |
Heron Therapeutics HRTX | $0.22 B | 23.45% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $99.07 M | -45.03% | ๐บ๐ธ USA |